In-Line Is Good Enough…for Today
publication date: Jan 7, 2014
Valeant Pharma issues in-line guidance for 2014, while Cray reiterates outlook. Shares of both companies soar.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.